NSC23925
Code | Size | Price |
---|
TAR-T16352-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T16352-50mg | 50mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
NSC23925 is a selective and effective inhibitor of P-glycoprotein (Pgp).
CAS:
858474-14-3
Formula:
C22H26Cl2N2O2
Molecular Weight:
421.36
Pathway:
Immunology/Inflammation
Purity:
0.98
SMILES:
Cl.Cl.COc1ccc(cc1)-c1cc(C(O)C2CCCCN2)c2ccccc2n1
Target:
Nrf2
References
1. Yang X, et al. Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis. Int J Cancer. 2015 Oct 15;137(8):2029-39.
2. Duan Z, et al. NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance. PLoS One. 2009 Oct 12;4(10):e7415.